Sun European Partners, LLP: DD Group Acquires Leading European Dental Distribution Platform DPI
Sun European Partners, LLP (“Sun European Partners” or “Sun European”), a leading private investment advisory firm focused on defensible businesses in growing markets with tangible performance improvement opportunities, today announces that its affiliated portfolio company DD Group has acquired 100% of the shares in Dental Promotion & Innovation SA (“DPI”) a leading dental distribution platform in continental Europe.
DPI is the largest dental distributor in Belgium, the third largest in France, and has a strong presence in Germany and the Netherlands. The transaction expands DD Group’s distribution coverage beyond the UK and Ireland into Western Europe and offers significant potential for synergies between the two businesses. DPI’s distribution capabilities will be added to DD Group’s current infrastructure, creating a pan-European leader in the distribution of dental consumables, equipment, laboratory services, aesthetics, and related services.
Value creation is expected to be driven through organic growth opportunities, underpinned by growing demand for dentistry and aesthetic treatments and realisation of synergies between the two businesses. Sun European will deploy its operational expertise to support the integration and identify areas for improved processes and efficiencies.
Alexander Wyndham, Principal, Sun European Partners LLP, said “the acquisition of DPI is a highly transformative deal for DD Group. For Sun European, our first objective following the acquisition of DD Group last year was to create a European leader, and we are delighted to see the business expanding. DPI has very strong growth prospects and the acquisition will act as a springboard for further bolt-ons across continental Europe.”
CEO of DD Group, Sam Tyrer, said “this acquisition represents a transformational moment in our company’s long history, being our first foray into continental Europe, enabling us to continue the company’s expansion and consolidate our presence in the European dental market. DD Group is acquiring a high-quality business with an outstanding team who have made an important contribution to the success and consistent growth of DPI over the past 20 years.”
David Vancutsem, DPI’s Founder and CEO, added “As founder and CEO of DPI, I am delighted to have found a like-minded and supportive partner in DD Group. We share the same ambitious aspirations for the business, and I look forward to working alongside DD Group as we aim to create Europe’s leading dental distribution platform.”
- Ends -
About Sun European Partners, LLP
Sun European Partners, LLP is a leading private investment advisory firm, focused on partnering with outstanding management teams to accelerate value creation. Since 1995, affiliates of Sun European have invested in more than 500 companies worldwide with revenues in excess of €40 billion across a broad range of industries and transaction structures. The Firm has built a reputation as a trusted partner, recognised for its operational experience. Sun European focuses on defensible businesses in growing markets with tangible performance improvement opportunities in the Business Services, Consumer, Healthcare, Industrial, and Technology sectors. Sun European Partners has offices in London and affiliates with offices in Boca Raton, Los Angeles, and New York.
For more information, please visit www.suneuropeanpartners.com.
About DD Group
Founded over 50 years ago, DD (formerly branded Dental Directory) is the only integrated distribution and demand creation platform for products and services for both dental and medical aesthetics customers. Through a unique ‘one-stop shop’, customers have access to over 30,000 dental and medical aesthetics products, prescription medicines, equipment and technology alongside dental engineering and compliance services. DD Group is an affiliated portfolio company of Sun European Partners, LLP.
About DPI
Founded in 2004, DPI is a leading European distributor of dental consumables and has its own laboratory to produce crowns and bridges. Headquartered in Anderlecht, the group services nearly 30,000 customers across Belgium, France, Germany, Netherlands and Luxembourg, with a strong focus on long term relationships with leading dental product manufacturers and complimented by excellent customer service and strong product availability.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230630686363/en/
Contact information
Media contacts:
S
un European Partners, LLP.
Camarco (United Kingdom)
Jen Renwick / Julia Tilley
+44 7928 471 013 / +44 7586 722 849
SunEuropeanPartners@Camarco.co.uk
Sun European Partners, LLP.
Bellier Financial (The Netherlands)
Jakob Geerts
Singel 266
1016 AC Amsterdam
The Netherlands
jakob.geerts@bellierfinancial.com
T: +31 20 419 0901
F: +31 6 8342 9715
DD Group
media@ddgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom